
A CANNABIS-BASED medicine has been approved for use for people living with multiple sclerosis (MS) in Scotland.
The Scottish Medicines Consortium approved the use of Sativex, which is the only drug in the UK licenced to treat the muscle stiffness and spasms – also known as spasticity – caused by MS.